Active Ingredient: ATAZANAVIR SULFATE; COBICISTAT
Proprietary Name: EVOTAZ
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 300MG BASE;150MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N206353
Product Number: 001
Approval Date: Jan 29, 2015
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO
Marketing Status:
Prescription
Patent and Exclusivity Information
